Solution Sensitivities, Incompatibilities & Adverse Reactions

Solution Sensitivities, Incompatibilities & Adverse Reactions

Quick Answer: Solution sensitivities are allergic or immune reactions to preservatives—thimerosal (mercury-based) has the highest historical sensitivity rate; polyquad the lowest. SICS (solution-induced corneal staining) appears as diffuse punctate staining 2–8 hours after insertion with certain SiHy + MPS combinations. Incompatibilities arise when a SiHy material sorbs a preservative, reducing disinfection and causing delayed toxicity. Management is to switch to hydrogen peroxide (preservative-free) or daily disposable lenses. Tap water exposure introduces Acanthamoeba and is categorically prohibited.

Solution Sensitivities (Preservative Allergies)

A solution sensitivity is a type IV (delayed hypersensitivity) immune reaction to a preservative in the care solution. Symptoms typically build over days to weeks of use and include:

• Redness, itching, burning on insertion
• Conjunctival injection, chemosis
• Follicles on the inferior palpebral conjunctiva ( hallmark sign)
• Papillary reaction in chronic cases
• Mucous discharge
• Foreign body sensation

Common Culprit Preservatives (Ranked by Sensitivity Risk)

Management of Preservative Sensitivity

1. Discontinue the offending solution
2. Switch to a hydrogen peroxide system — preservative-free after neutralization, eliminates further preservative exposure
3. Consider daily disposable lenses — eliminates the care system entirely, ideal for recurrent sensitizers
4. Counsel the patient that symptoms should resolve within 1–2 weeks of switching; persistent symptoms warrant evaluation for GPC or other causes

Incompatibilities: Preservative Sorption by SiHy Materials

Silicone hydrogel lenses have variable surface chemistry. Some SiHy materials (notably older generations with plasma surface treatment or certain wetting agents) sorb preservatives from MPS into the lens matrix. Two clinical consequences follow:

1. Reduced disinfection efficacy — the preservative concentration in solution drops below the effective kill threshold
2. Delayed preservative release — the lens releases the bound preservative onto the cornea after insertion, causing toxicity or hypersensitivity

This is the mechanism behind SICS (solution-induced corneal staining). The classic presentation is diffuse punctate staining 2–8 hours after insertion in a SiHy wearer using a PHMB-based MPS. Polyquad-based MPS is generally less prone to SICS because the larger molecule does not penetrate the lens matrix as readily.

SICS Clinical Features

• Onset 2–8 hours after lens insertion
• Diffuse, fine punctate staining across the cornea
• Mild irritation or foreign body sensation; may be asymptomatic
• Bilateral, symmetrical pattern
• Resolves when the offending solution is discontinued

Management of SICS

• Switch to a polyquad-based MPS or peroxide system
• Verify SiHy material compatibility in the solution manufacturer's labeling
• Document the reaction in the patient record
• Re-evaluate at 1 week to confirm resolution

Adverse Reactions Beyond SICS

Solution Toxicity

Solution toxicity is a direct chemical injury to the corneal epithelium, distinct from hypersensitivity. Causes include:

• Inserting a lens from an unneutralized peroxide case (chemical burn)
• Using a daily cleaner without rinsing completely
• Using expired or contaminated solution
• Using a solution not approved for the lens material

Toxicity presents with acute, severe punctate staining, often in a pattern matching the lens edge or pooling zone, accompanied by pain, redness, and tearing.

Papillary Reaction to Solutions

Chronic preservative exposure can trigger a papillary reaction that resembles GPC but is solution-driven. Signs include:

• Large papillae on the upper tarsal conjunctiva
• Mucous discharge
• Itching and lens intolerance

Switching to peroxide or daily disposable lenses typically resolves the reaction over 2–4 weeks.

Contact Lens–Induced Peripheral Ulcer (CLPU)

CLPU is a sterile inflammatory peripheral corneal infiltrate associated with solution contamination, lens case biofilm, or gram-positive bacterial antigens trapped under the lens. Features:

• Small (1–2 mm) white peripheral infiltrate
• Moderate pain, redness, tearing
• Often unilateral
• No epithelial defect over the infiltrate (sterile)

CLPU must be differentiated from microbial keratitis (which has an epithelial defect, larger infiltrate, and progressive course). Management includes discontinuing lens wear, replacing the lens and case, switching solutions, and referral to rule out infection.

Solution Contamination and the Lens Case

The lens case is the most common source of solution contamination in CL practice. Biofilm forms on the case walls within days of use. Risk factors for case contamination include:

• Not rubbing and rinsing the case daily
• Reusing old solution ("topping off")
• Storing the case in a humid bathroom
• Not replacing the case every 3 months

Counseling points for case hygiene:

• Rub and rinse the case with fresh solution after each use
• Air-dry the case upside-down on a clean tissue
• Replace the case at least every 3 months (or with each new bottle of solution)
• Never top off solution—discard and refill completely

Tap Water: Acanthamoeba Risk

Tap water exposure is the single most preventable risk factor for Acanthamoeba keratitis, a devastating protozoal infection with poor treatment outcomes. Risk scenarios include:

• Rinsing lenses or the case under the faucet
• Showering in lenses
• Swimming in lenses (pool, lake, ocean, hot tub)
• Using homemade saline or distilled water
• Storing lenses in non-sterile water overnight

Acanthamoeba keratitis presents with severe pain out of proportion to findings, ring infiltrate, epithelial irregularity, and a course that can mimic HSV keratitis. Suspected Acanthamoeba is an ocular emergency requiring immediate ophthalmology referral.

Documentation and Follow-Up

When a solution-related adverse reaction is identified, document:

• The specific solution, lot number, and manufacturer
• The lens material and parameters
• The clinical findings (staining pattern, injection, follicles/papillae)
• The management plan (switch to peroxide, change lens modality, etc.)
• Patient education provided
• Follow-up interval

This documentation supports both patient care and FDA MedWatch adverse event reporting when warranted.